TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›HSCT

HSCT

HOOPS SCOUTING USA

Next earnings ≈ Aug 24, 2026 · est. from filing cadence

Hold
$0.02
▲ 0.00%
$0.02▼ -77.80%
over 1Y
L $0.02H $0.35
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+0.0%
1M+0.0%
3M+0.0%
YTD+0.0%
1Y-77.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)

Conservative balance sheet (liabilities/equity -1.43x).

Revenue (FY2019) $0.00 · FY2019

HOOPS SCOUTING USA shows $0.00 in FY2019 revenue, and 11.4% ROE.

Supporting the case: conservative balance sheet (liabilities/equity -1.43x).

Is HSCT a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income—————
Net income-$36.6K-$52.4K-$124K-$50.9K-$20.1K
Diluted EPS———$0.00$0.00
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.02M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-1.0%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash$20.00
Piotroski F-Score2/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — restated periodic report (2025-10-14). Worth a closer look.
  1. 10-Q Quarterly report2026-05-13
  2. 10-Q Quarterly report2026-01-30
  3. 10-Q Quarterly report2026-01-30
  4. 10-K Annual report2026-01-13
  5. 10-Q Quarterly report2025-12-19
  6. 10-Q Quarterly report2025-12-19
  7. 10-Q Quarterly report2025-12-19
  8. 10-Q/A Restated periodic report2025-10-14
  9. 10-Q/A Restated periodic report2025-10-14

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-05-13open ↗10-QPeriod ending 2025-09-302026-01-30open ↗10-QPeriod ending 2025-12-312026-01-30open ↗10-KPeriod ending 2025-06-302026-01-13open ↗10-QPeriod ending 2025-03-312025-12-19open ↗10-QPeriod ending 2024-12-312025-12-19open ↗10-QPeriod ending 2024-09-302025-12-19open ↗10-Q/APeriod ending 2024-03-312025-10-14open ↗10-Q/APeriod ending 2023-12-312025-10-14open ↗10-Q/APeriod ending 2023-09-302025-10-14open ↗10-KPeriod ending 2024-06-302025-08-29open ↗10-K/APeriod ending 2023-06-302025-08-28open ↗

Quality score

D
ValueGrowthProfitHealthMom.
Value—
GrowthA+
Profitability—
Financial healthF
MomentumF
  • ✗Profitable (positive net income)
  • ✓Liabilities below 2× equity
0.0252-week0.09
Revenue
$0.00
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

■ revenue · ■ net income, by fiscal year

Revenue$0.00
Net income-$20.1K+60.5%
Diluted EPS$0.00
Cash & equivalents$20.00-73.7%
Total assets$76.9K-0.1%
Total liabilities$254K+8.6%
Stockholders' equity-$177K-12.8%
L/E: -1.43x

Frequently asked

Is HOOPS SCOUTING USA (HSCT) a buy?
HSCT currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -1.43x).
What is HOOPS SCOUTING USA's quality score?
HSCT scores 47.272727272727266/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001721056, latest 10-Q filed 2026-05-13) · EODHD · as of 6/18/2026, 12:39:04 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 8:39 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score47 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2